Insulin pen company raises EUR 2.5m
The European Innovation Council has given Go-Pen a capital injection – proceeds that will be spent on developing and marketing a new, affordable, insulin pen.
by astrid sturlason, translated by daniel pedersen
Go-Pen has just received a EUR 2.5m injection from the European Innovation Council to continue developing the company’s new type of insulin pen, which promises affordability for all, writes Danish financial media Finans. An additional EUR 4m is at the ready if Go-Pen can find and match the same sum in external financing.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo's insulin pen return system launched successfully
For subscribers
French Biocorp enters smart pen partnership with Merck
For subscribers
